Pfizer vs Structure Therapeutics: Revenue Comparison
Pfizer (PFE) and Structure Therapeutics (GPCR) are peers in GLP-1. Pfizer reported revenue of $14.5B as of Q1 2026, compared with $0 for Structure Therapeutics. Pfizer leads on revenue.
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Pfizer 14.451, Structure Therapeutics 0.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, Structure Therapeutics.| Metric | Pfizer | Structure Therapeutics |
|---|---|---|
| Market Cap | - | - |
| Revenue | $14.45B | $0 |
| Cost of Revenue | $4.73B | $1.00M |
| Gross Profit | $9.72B | $-1.00M |
| Operating Income | $4.03B | $-90.00M |
| Net Income | $2.69B | $-76.00M |
| R&D Expense | $2.63B | $67.00M |
| Earnings Per Share | $0.47 | -$1.05 |
| Gross Margin | 67.3% | - |
| Operating Margin | 27.9% | - |
| Net Profit Margin | 18.6% | - |
| Free Cash Flow | $2.18B | $14.00M |
| Cumulative Free Cash Flow | $356.40B | $-469.00M |
| Operating Cash Flow | $2.62B | $15.00M |
| Cash & Equivalents | $1.70B | $316.00M |